13:56:29 EDT Sat 10 Jun 2023
Enter Symbol
or Name
USA
CA



MCI Onehealth Technologies Inc
Symbol DRDR
Shares Issued 50,075,202
Close 2022-09-21 C$ 0.99
Recent Sedar Documents

MCI Onehealth, Oro release MCI Dermatology Connect

2022-09-21 17:25 ET - News Release

Dr. Alexander Dobranowski reports

MCI ONEHEALTH AND ORO HEALTH COLLABORATE TO LAUNCH NEW TELEDERMATOLOGY PLATFORM

MCI Onehealth Technologies Inc. and Oro Health, a provider of asynchronous telemedicine, combined with artificial-intelligence-based solutions for medical specialists, have launched collaboratively developed MCI Dermatology Connect. The launch of MCI Dermatology Connect will help meet the need of Ontarians currently waiting for a consultation on minor dermatological conditions, lessen wait times and increase Ontarians' access to dermatologists regardless of geographic constraints.

"Quick, convenient access to specialists with top-quality continuity of care is a cornerstone of the patient experience in MCI's high performance health care network. This collaboration with Oro Health expands our convenient virtual care offering and accelerates access to specialty care," said Dr. Alexander Dobranowski, chief executive officer of MCI Onehealth. "Additionally, this innovative platform creates a unique draw for the recruitment of specialists to our network, so that even more patients can be given the care they need quickly. MCI is firmly committed to our mission to make health care more accessible, affordable and ultimately safer, and we're grateful for innovative partners like Oro Health who share this goal."

The MCI Dermatology Connect platform provides specific solutions needed for virtual dermatology care, including secure transfer of high-resolution imaging between patient and specialist. The innovative platform utilizes Oro Health technology that employs dynamic intelligent triage, facilitating swift categorization and assessment of a patient's dermatological condition. Integrated tools such as predefined templates for prescriptions, diagnosis and treatment cultivate a streamlined care environment for both MCI Onehealth patients and practitioners. Moreover, asynchronous teledermatology eliminates the necessity for set appointments between the patient and physician, widening the possibilities for swift physician response and the delivery of appropriate care, leading to expected improvements in patient experience and health outcomes. The collaboration accelerates MCI Onehealth's vision to transform primary care delivery with precision medicine technologies, novel referral optimization and custom tech-forward initiatives.

"We are excited to collaborate with MCI Onehealth and provide our technology to enable a new teledermatology on-line consultation service for Ontario-based patients awaiting faster and broader access to dermatological care," said Dr. Emilie Bourgeault, chief executive officer of Oro Health, BSc, MD, dermatologist (FRCPC).

MCI Onehealth is already a leader in the virtual/telehealth care sector with 300,000 annual patient visits by telephone or MCI Onehealth's general health virtual platform, MCI Connect. This collaboration with Oro Health demonstrates MCI Onehealth's continued commitment to the expansion of technology-enabled care. In the absence of more providers and resources, greater technological innovation, clinical efficiency and data that are used well can flag gaps in care, target patients for services they are behind on, provide patients with more options and help reduce health system costs.

MCI Onehealth has built a first-of-its-kind model in community health care that is right now demonstrating efficiencies and improving patient access in ways that has not been demonstrated before in Canadian health care. MCI Onehealth's technology- and data-enabled high performance health care network helps address urgent health system issues: remedying system backlogs for patient services, providing greater access to care and diagnostics, providing high-quality continuity of care, speeding time to specialist referrals, and identifying optimal care pathways, while accelerating research that supports new health treatments and products.

"MCI's high performance health care network of patient-facing services allows it to build a much richer and deeper patient profile. Our collaboration with Oro Health, a leader in asynchronous telemedicine with image-based AI-driven triaging, will lead to future opportunities to enhance that patient profile, make care more personalized and preventative, and expand the scope of data-driven insights," added Dr. Dobranowski.

Currently, MCI Onehealth provides data insights as a service in six categories: rare disease; complex major medical/chronic; patient cohort building; clinical trial recruitment; synthetic health data; and bespoke insights. Such services are targeted at pharmaceutical companies, life science companies, precision medicine companies and top-tier university centres.

About MCI Onehealth Technologies Inc.

MCI Onehealth is a health care technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality and reduce health care costs. As part of the health care community for over 30 years, MCI Onehealth operates one of Canada's leading primary care networks with nearly 260 physicians and specialists, serves more than one million patients annually, and had nearly 300,000 telehealth visits last year, including on-line visits. MCI Onehealth additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. Led by a proven management team of doctors and experienced executives, MCI Onehealth remains focused on executing a strategy centred around acquiring technology and health services that complement the company's current road map.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.